Atsena Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-114/11/25 | New | $89,999,975 | $89,999,975 | Equity Only | 06b | SEC linkSEC |
| 2023-10-0210/2/23 | New | $24,474,387 | $24,474,387 | Equity Only | 06b | SEC linkSEC |
| 2020-12-2312/23/20 | New | $27,499,973 | $27,499,973 | Equity Only | 06b | SEC linkSEC |
| 2020-05-085/8/20 | New | $4,074,989 | $4,074,989 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Shannon Boye | Director |
| Sanford Boye | Executive |
| Chris Carpenter | Director |
| Michael Dial | Director |
| Jacqueline Grant | Director |
| James Healy | Director |
| Christina Isacson | Director |
| Elizabeth Leiderman | Executive |
| Norbert Riedel | Director |
| Patrick Ritschel | Director, Executive |
| Jennifer Wellman | Director |
| Benjamin Yerxa | Director |
| Joe Zakrzewski | Director |
Industry: Biotechnology (See others in industry)
Address:
8 Davis Drive, Suite 300
Durham, NC, 27709
Phone: 984-261-2001
Durham, NC, 27709
Phone: 984-261-2001